CSL’s new brand positioning is actually its first—and it comes after more than 100 years in business. CSL, the parent of biotherapy maker CSL Behring and its flu vaccine division Seqirus, was originally founded as a government agency in Australia in 1916 to source therapies for the then-isolated island country. But CSL has since come a long way.Original Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.